1. Home
  2. Detail

@humomomomo: F 🔥Meilleure vente mondiale ! Retrouvez votre pleine forme ! Une marque de santé centenaire ! Recommandée par les médecins ! Huile de krill norvégienne importée, pour préserver votre santé.-635697-

kitchen artifact
kitchen artifact
Open In TikTok:
Region: JP
Tuesday 11 November 2025 10:13:48 GMT
636
7
0
1

Music

Download

No Watermark .mp4 (9.61MB) No Watermark(HD) .mp4 (6.74MB) Watermark .mp4 (9.75MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @humomomomo, please go to the Tikwm homepage.

Other Videos

#سيد_علي_الخامنئي #علي_الخامنئي #ايران #تصميم_فيديوهات🎶🎤🎬 #الشعب_الصيني_ماله_حل😂😂
#سيد_علي_الخامنئي #علي_الخامنئي #ايران #تصميم_فيديوهات🎶🎤🎬 #الشعب_الصيني_ماله_حل😂😂
chill video) #gojo #gojosatoru #jjk #jujutsukaisen
chill video) #gojo #gojosatoru #jjk #jujutsukaisen
#ፍቅር➻ብቻ🖇ፍቅር➻ብቻ❤🥀🔐 #ethiopian_tik_tok🇪🇹🇪🇹🇪🇹🇪🇹 #💔
#ፍቅር➻ብቻ🖇ፍቅር➻ብቻ❤🥀🔐 #ethiopian_tik_tok🇪🇹🇪🇹🇪🇹🇪🇹 #💔


GLP-1 medications work. Weight comes off, appetite quiets, and metabolic numbers improve. But what most aren't told is that GLP-1s change the body fast enough that the labs you walked in with are no longer the ones you should be tracking. The medication is doing real work. Monitoring must keep up. Most prescribers run a baseline, hand you the script, and check in every six to twelve months — missing what's shifting underneath. The body recomposes faster than the standard follow-up schedule was designed to catch. Check these every three months on a GLP-1: Fasting insulin and HbA1c → speed of change matters. Quarterly tracking shows if the medication is correcting dysfunction or just suppressing appetite. They look identical on the scale and different on labs. Comprehensive metabolic panel (CMP) → GLP-1s can affect kidney function and electrolytes. A quarterly CMP catches early shifts in creatinine and eGFR. Lipid panel with ApoB → lipids change fast with weight loss. ApoB tracks atherogenic burden more accurately than LDL while composition shifts. Standard panels can look better while ApoB tells a different story. Ferritin and iron panel → rapid loss drives iron deficiency. Ferritin under 30 in women and under 50 in men is functionally low. Iron status affects energy and mood — often blamed on the medication when the cause is depletion. Vitamin D, B12, and folate → lower food volume means lower nutrient intake. Deficiencies in these three are common and easy to correct once identified. Thyroid panel (TSH, free T3, free T4) → rapid loss can shift thyroid function and drive fatigue. Quarterly monitoring catches these shifts early. hs-CRP → inflammation should drop. If CRP isn't moving, something else is driving inflammation. Lean mass markers (creatinine trends, albumin) → muscle loss is a risk. Creatinine trending down out of proportion to weight loss can signal the loss isn't just fat. Quarterly tracking is essential. The trajectory matters most — whether metabolic improvement is durable and lean mass is preserved. Once-a-year monitoring is not enough for a body changing this fast. The goal is to leave you in a better metabolic place. The only way to know is to measure it. Ensure labs are keeping up with the work the medication is doing. @superpower runs the comprehensive panel worth tracking every three months on a GLP-1 — fasting insulin, HbA1c, full metabolic panel, ApoB, ferritin, full iron panel, vitamin D, B12, folate, thyroid, hs-CRP, and 90+ other biomarkers most prescribers don't order on follow-up. This is for education only and not medical advice.
GLP-1 medications work. Weight comes off, appetite quiets, and metabolic numbers improve. But what most aren't told is that GLP-1s change the body fast enough that the labs you walked in with are no longer the ones you should be tracking. The medication is doing real work. Monitoring must keep up. Most prescribers run a baseline, hand you the script, and check in every six to twelve months — missing what's shifting underneath. The body recomposes faster than the standard follow-up schedule was designed to catch. Check these every three months on a GLP-1: Fasting insulin and HbA1c → speed of change matters. Quarterly tracking shows if the medication is correcting dysfunction or just suppressing appetite. They look identical on the scale and different on labs. Comprehensive metabolic panel (CMP) → GLP-1s can affect kidney function and electrolytes. A quarterly CMP catches early shifts in creatinine and eGFR. Lipid panel with ApoB → lipids change fast with weight loss. ApoB tracks atherogenic burden more accurately than LDL while composition shifts. Standard panels can look better while ApoB tells a different story. Ferritin and iron panel → rapid loss drives iron deficiency. Ferritin under 30 in women and under 50 in men is functionally low. Iron status affects energy and mood — often blamed on the medication when the cause is depletion. Vitamin D, B12, and folate → lower food volume means lower nutrient intake. Deficiencies in these three are common and easy to correct once identified. Thyroid panel (TSH, free T3, free T4) → rapid loss can shift thyroid function and drive fatigue. Quarterly monitoring catches these shifts early. hs-CRP → inflammation should drop. If CRP isn't moving, something else is driving inflammation. Lean mass markers (creatinine trends, albumin) → muscle loss is a risk. Creatinine trending down out of proportion to weight loss can signal the loss isn't just fat. Quarterly tracking is essential. The trajectory matters most — whether metabolic improvement is durable and lean mass is preserved. Once-a-year monitoring is not enough for a body changing this fast. The goal is to leave you in a better metabolic place. The only way to know is to measure it. Ensure labs are keeping up with the work the medication is doing. @superpower runs the comprehensive panel worth tracking every three months on a GLP-1 — fasting insulin, HbA1c, full metabolic panel, ApoB, ferritin, full iron panel, vitamin D, B12, folate, thyroid, hs-CRP, and 90+ other biomarkers most prescribers don't order on follow-up. This is for education only and not medical advice.
@Latinbeauty
@Latinbeauty

About

Legal